LabMed

Elevated Serum Calcium

Differential Diagnosis

Primary hyperparathyroidism

  • Excess parathyroid hormone (PTH) secretion from a single parathyroid adenoma, hyperplasia of the parathyroids, parathyroid carcinoma

Malignant tumors

  • Especially tumors of the breast, lung, and kidney in which hypercalcemia may occur from direct bony metastasis

  • Multiple myeloma that directly degrades bone

  • Other cancers that produce hypercalcemia by inducing PTH secretion

Excess vitamin D intake

  • Prolonged use of diuretics and thiazides known to produce hypercalcemia

Dangerous Situations

Severe hypercalcemia favors a diagnosis of cancer.

Commonly Encountered Situations

Hypercalcemia from malignancy is especially common.

Suggested Additional Lab Testing

In primary hyperparathyroidism, serum PTH is increased and serum phosphorus is decreased.

In hypercalcemia of malignancy, serum phosphorus is decreased in approximately 50% of patients, and there is a decrease in the serum PTH in these patients.

Serum protein electrophoresis is useful in the assessment for multiple myeloma. Serum 1,25-dihydroxy vitamin D is low in hypercalcemia of malignancy. It is often increased in primary hyperparathyroidism.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters